Seroincidence Rate of Typhoidal Salmonella in Children, Kenya, 2017–2018

https://wwwnc.cdc.gov/eid/article/32/3/25-0469_article

Oestrus ovis Nasal Myiasis with Pupation in Human Host, Greece, October 2025

https://wwwnc.cdc.gov/eid/article/32/3/25-1077_article

lsaC and Tandem lsaE-lnuB Resistance Genes in Invasive Group A Streptococcus

https://wwwnc.cdc.gov/eid/article/32/3/25-1776_article

Natural Hendra Virus Infections in Captive Australian Black Flying Foxes, Queensland, Australia

https://wwwnc.cdc.gov/eid/article/32/3/25-1350_article

Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan

https://wwwnc.cdc.gov/eid/article/32/3/25-1418_article

Two Cases of Posttraumatic Kosakonia Infection, Argentina, 2023

https://wwwnc.cdc.gov/eid/article/32/3/25-1714_article

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group

https://wwwnc.cdc.gov/eid/article/32/3/25-1165_article

Tuberculosis before and during COVID-19 Pandemic, United States, 2010–2023

https://wwwnc.cdc.gov/eid/article/32/3/25-1459_article

Extraintestinal Entamoeba moshkovskii Infection, Eastern India

https://wwwnc.cdc.gov/eid/article/32/3/25-1065_article

CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo

https://wwwnc.cdc.gov/eid/article/32/3/25-1171_article

Mycobacterium nanjing sp. nov. Isolated from Cutaneous Infection, China

https://wwwnc.cdc.gov/eid/article/32/3/25-2001_article

Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe

https://wwwnc.cdc.gov/eid/article/32/3/25-1775_article

Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA

https://wwwnc.cdc.gov/eid/article/32/3/25-1042_article

Dracunculiasis, 1674

https://academic.oup.com/cid/article/82/3/i/8525105?rss=1

State-of-the-Art Review: Managing Vulvovaginal Candidiasis

https://academic.oup.com/cid/article/82/3/371/8525096?rss=1

In the Literature

https://academic.oup.com/cid/article/82/3/ii/8525071?rss=1

A Bloom Beneath the Skin

https://academic.oup.com/cid/article/82/3/535/8525037?rss=1

Persistent Fever and Back Pain After Liver Transplantation

https://academic.oup.com/cid/article/82/3/522/8525032?rss=1

[Corrections] Correction to Lancet Infect Dis 2026; published online Jan 28. https://doi.org/10.1016/S1473-3099(25)00747-9
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00120-9/fulltext?rss=yes

Heysell SK, Mpagama SG, Nuwagira E, et al. Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial. Lancet Infect Dis 2026; published online Jan 28. https://doi/org/10.1016/S1473-3099(25)00747-9—In this Article, the p value in the Findings in the Summary for patients with microbiologically confirmed tuberculosis in the diagnosis-dependent high-dose group compared with the diagnosis-dependent conventional-dose group should have been 0·079.

[Profile] Katharina Kranzer—led by curiosity, committed to capacity
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00127-1/fulltext?rss=yes

Katharina Kranzer has always wanted to understand how things work. As a child moving between the USA, Austria, and Germany due to her father's work as a physicist, she developed early a habit of examining systems from the outside. She briefly considered studying history and politics, but her mother helped convince her medicine offered something more tangible: a way to interrogate the world and change it. At the Technical University of Munich, Germany, where she chose to study in part to be close to the mountains she loved, it was not the routine of clinical training that captivated her.

[Editorial] GoGoVax dispels hopes for gonorrhoea vaccination
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00126-X/fulltext?rss=yes

In 2020, WHO estimated that there were 82·4 million new infections with Neisseria gonorrhoeae among adults aged 15–49 years and up to 2022, the incidence of gonorrhoea had been on the rise globally for a decade. While in the last three years a decrease in the number of cases has been observed in several countries, including the USA and the UK, with antimicrobial resistance constituting a major barrier to treatment and no gonorrhoea vaccine available, protecting populations at risk from the disease remains a challenge.